신경학 분야 디지털 헬스 시장 규모, 점유율 및 동향 분석 보고서 : 구성 요소별, 최종 용도별, 지역별 및 부문별 전망(2026-2033년)

The global digital health in neurology market size was valued at USD 48.5 billion in 2025 and is projected to grow from USD 59.4 billion in 2026 to USD 246.9 billion in 2033, at a CAGR of 22.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. Increasing smartphone penetration, advancing healthcare IT infrastructure, improved internet connectivity, increasing prevalence of chronic diseases, rising healthcare expenditure, growing demand for remote patient monitoring services, and increasing accessibility of virtual care are driving the adoption of digital health technologies in neurology.

The global healthcare sector has encountered numerous challenges during the pandemic. However, these circumstances accelerated the advancement of digital health technologies, especially in disease management, technology development, and frontline care delivery. Many countries have adopted remote monitoring platforms, telemedicine, and telehealth services to facilitate communication between physicians and patients. As a result, the digital health industry experienced significant revenue growth and is expected to continue growing profitably in the coming years, maintaining rapid expansion throughout the forecast period.

Government initiatives promoting global digitalization in healthcare are significantly driving market growth. For example, in January 2024, the European Commission awarded an EU-funded collaborative research infrastructure (RI) grant of approximately USD 41 million to EBRAINS, which will last until 2026. This funding will assist EBRAINS in developing tools and services, such as digital twin approaches, to support communities in brain medicine, neuroscience, and brain-inspired technologies.

The Internet of Things (IoT) has been widely adopted as a digital healthcare platform. With advanced wearable devices, reliable mobile connectivity, and efficient data backup enabled by integrated analytics, IoT has transformed the healthcare industry by facilitating a range of activities. These include efficient tracking of patients, staff, and inventories, managing chronic conditions, optimizing drug prescriptions, and ensuring the availability of essential medical equipment. For instance, in April 2025, Phantom Neuro announced the successful completion of a USD 19 million Series A funding round led by Ottobock to expedite the development and commercialization of its muscle-machine interface technology. This funding will support regulatory activities, product development, and clinical validation of Phantom X, an AI-powered neural interface designed to enable intuitive control of prosthetic limbs and robotic devices.

Smartphones have transformed from simple entertainment and communication devices into essential tools for fitness and health tracking. Health-related applications have made it easier to manage daily activities by offering convenient ways to monitor overall well-being. For example, some companies are developing applications to track sleep patterns. In July 2025, Apollo Neuroscience released Version 4.0 of its Apollo mobile application, which included a redesigned user interface, personalized content recommendations, improved SmartVibes integration, and better connectivity with wearables. These enhancements aim to strengthen the digital therapeutic experience for stress management and neurological well-being.

Similarly, according to the World Health Organization estimates, there are approximately 55 million individuals across the globe suffering from dementia. The consequences are many individuals suffering from the conditions and substantial healthcare costs. According to the World Health Organization's Global Status Report on Neurology published in 2025, neurological conditions now affect more than 40% of the global population, representing over 3 billion people, and remain the leading cause of ill health and disability worldwide. Hence, several companies and research institutes are investing in clinical trials, including the application of digital technologies in neurology.

Global Digital Health In Neurology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global digital health in neurology market report based on component, end use, and region:

• Component Outlook (Revenue, USD Million, 2021 - 2033)

Software

Hardware

Services

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

Patients

Providers

Payers

Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Italy
• Spain
• Sweden
• Denmark
• Norway

Asia Pacific

• China
• India
• Japan
• Australia
• South Korea
• Singapore

Latin America

• Brazil
• Mexico
• Argentina

MEA

• South Africa
• Saudi Arabia
• UAE
• Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Component
  • 1.1.2. End Use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component outlook
  • 2.2.2. End Use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Digital Health In Neurology Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing adoption of digital technology in neurology care
    • 3.2.1.2. Increasing use of artificial intelligence (AI), internet of things (IoT), and big data
    • 3.2.1.3. Growing adoption of mobile health applications and technologies
    • 3.2.1.4. Increasing burden of neurological disorders
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Privacy and security concerns
    • 3.2.2.2. Lack of healthcare infrastructure
• 3.3. Digital Health In Neurology Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Digital Health In Neurology Market: Component Estimates & Trend Analysis

• 4.1. Definition and Scope
• 4.2. Component Market Share, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Digital Health In Neurology Market by Component Outlook
• 4.5. Software
  • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.6. Hardware
  • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.7. Services
  • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Digital Health In Neurology Market: End Use Estimates & Trend Analysis

• 5.1. Definition and Scope
• 5.2. End Use Market Share, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Digital Health In Neurology Market by End Use Outlook
• 5.5. Patients
  • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 5.6. Providers
  • 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 5.7. Payers
  • 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Digital Health In Neurology Market: Regional Estimates & Trend Analysis, By Component, By End Use

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. SWOT Analysis, by Region
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework/ reimbursement structure
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework/ reimbursement structure
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework/ reimbursement structure
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework/ reimbursement structure
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.6. Singapore
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework/ reimbursement structure
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework/ reimbursement structure
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8.2. Mexico
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework/ reimbursement structure
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework/ reimbursement structure
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework/ reimbursement structure
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework/ reimbursement structure
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework/ reimbursement structure
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework/ reimbursement structure
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. Key company market share analysis, 2025
  • 7.3.2. Neofect
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Teladoc
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Proteus Digital Health
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Akili Labs
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. AppliedVR
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Aural Analytics
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. BehaVR
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. BetterHelp
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Big Health
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Omada Health
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Blackrock Neurotech
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. AdvancedMD
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives